Aging and menopause related decline in circulating levels of estrogen has been shown to adversely affect female sexual arousal function. Our aim was to study the effects of circulating levels of estrogen on the hemodynamic mechanism of vaginal and clitoral engorgement and on the structure of the vaginal and clitoral cavernosal tissue in the rabbit.
Introduction
The role of estrogen in the regulation of female sexual arousal function has been frequently reported. 1 ± 3 Estrogens are known to be vasoprotective and regulate vascular smooth muscle tone. 1, 2 In the clinical studies, correlation between circulating levels of estrogen and the status of blood¯ow in the vagina, clitoris and urethra has been well documented. 1, 2 It has been shown that estrogen replacement therapy in post-menopausal women restores clitoral and vaginal vibration and pressure threshold to the levels of pre-menopausal women. 1 Studies with animal models have shown that treatment with estradiol increases the touch receptor zone along the pudendal nerve and improves sensory threshold. 3 It was recently reported that approximately 43% of women complain about sexual dissatisfaction. 4 The major complaints include loss of desire, painful intercourse, dif®culty achieving orgasm and decreased frequency of sexual activity. 4 Several studies have shown that female sexual arousal disorders increase with age and menopause and correlate with the decline in circulating levels of estrogen. 1, 2, 5 Our studies with human clitoris showed that aging women undergo histological changes in the clitoral erectile tissue. 6 Clinical studies have shown that decrease in vaginal blood ow and diminished vaginal secretion during menopause signi®cantly correlates with the decline in circulating ovarian hormones. 2 It is also reported that estrogen replacement therapy enhances pelvic blood¯ow in post-menopausal women. 2 In our previous studies with the rabbit model, we found that the development of vaginal and clitoral engorgement depends on an adequate increase in the vaginal wall and clitoral intracavernosal blood ows. 7 We also found that occlusive disease of the iliac and pudendal arteries reduced arterial in¯ow to the vagina and clitoris and impaired vaginal and clitoral engorgement. 7 Studies with a rat model showed that estrogen withdrawal resulted in vaginal atrophy, intramural collagen accumulation and structural changes in vaginal wall microvasculature. 8 These structural changes were shown to diminish by estrogen replacement therapy. 8 Despite evidence of female sexual arousal dysfunction in conjunction with hormonal changes during menopause, the precise mechanisms by which sex hormone insuf®ciency interfere with female sexual arousal function are unknown.
Our aim was to study the mechanisms by which decreased levels of circulating estrogen impair the hemodynamics of vaginal and clitoral engorgement in the rabbit. We also examined whether decreased circulating levels of estrogen lead to structural damage in the vaginal wall and clitoral cavernosal tissues. Another aim was to determine whether estrogen replacement therapy could prevent oophorectomy-induced hemodynamic and structural changes in the vaginal and clitoral cavernosal tissues.
Materials and methods

Experimental model
The New Zealand White female rabbits (3.5 ± 4 kg) were randomly divided into oophorectomy (O), oophorectomy with estrogen replacement (OE) and control groups. The O (n 5) group underwent bilateral oophorectomy alone. The OE (n 5) group underwent bilateral oophorectomy followed by treatment with subcutaneous estradiol on a daily basis (40 mgakg). The control group (n 5) did not undergo oophorectomy or estrogen treatment.
After 6 weeks, the animals were anesthetized with intramuscular injections of ketamine (50 mgakg). Anesthesia was maintained with intravenous injections of pentobarbital (25 mgakg) as needed. A 20-gauge angiocatheter was placed into the femoral artery for measurement of arterial blood pressure. A midline abdominal incision was made and the vaginalaclitoral branch of the pelvic nerve was exposed. The clitoris and corresponding corporal bodies were exposed via a dorsal midline incision. A Harvard subminiature electrode was placed around the vaginalaclitoral branch of the pelvic nerve. Unilateral nerve stimulation was performed at 10 V, 8 msec and 16 Hz delivered for 20 sec.
Measurement of vaginal and clitoral intracavernosal blood¯ows
Vaginal mucosal blood¯ow was measured by a surface type laser Doppler¯ow probe placed on the vaginal mucosa 2 ± 3 cm proximal to the vaginal introitus. Clitoral intracavernosal blood¯ow was measured with a needle type laser Doppler¯ow probe placed directly into the cavernosal tissue. Thē ow probes were connected to a dual channel laser Doppler¯owmeter (Transonic Systems, Inc.) which was calibrated against an internal standard readinḡ ow in units of mlamina100 g of tissue.
Histology and histomorphometric image analysis
The lower third of vaginal tissue was dissected from both lateral walls. The clitoris was removed and the corpus cavernosum tissue was dissected. The tissues were placed in phosphate buffered paraformaldehyde for 3 h and then processed for washing and dehydration. The tissues were routinely embedded in paraf®n and 5 mm sections were prepared. Tissues were stained with hematoxylin and eosin or Masson's trichrome. Percentage of smooth muscle in clitoral cavernosal tissue was assessed by computerassisted histomorphometric image analysis of Masson's trichrome stained slides. Fifteen to twenty different high power ®elds (Â200 magni®cation) were randomly selected and analyzed for each specimen. The percentage of smooth muscle was calculated for every high power ®eld as the sum of red stained areas divided by the sum of all red and blue stained areas which represented the ratio of smooth muscleXtotal cavernosal tissue. During high power ®eld selection, care was taken not to include clitoral tunica albuginea, intracavernosal septum or cavernosal artery or vein in the examined area. Because of the unique histology of the vaginal tissue, histomorphometry of the vaginal wall was not possible with our existing image analysis system.
Measurement of circulating levels of estrogen
Before hemodynamic studies, a blood sample (2 ml) was obtained from the femoral artery. The serum concentration of 17b-estradiol was determined by radioimmunoassay using Coat-A-Count Estradiol kit (Diagnostic Products Co, CA). The Coat-A-Count Estradiol procedure is based on antibody-coated tubes. Labeled estradiol competes with estradiol in the sample for antibody sites. The quantity of estradiol in the sample is determined by comparing the counts to a calibration curve.
Statistical analysis
The data is expressed as mean AE standard deviation of the mean. Paired Student's t-test was utilized to compare changes within the group. ANOVA was utilized for comparison of data among the groups. Statistically signi®cance was determined at P`0.05.
Results
Alterations in the circulating levels of estrogen
The mean serum level of 17b-estradiol was signi®-cantly decreased in the O group (25.4 AE 5.1 pgaml) compared with the control group (38.5 AE 7.6 pgaml; PK`0.05). In the OE group, however, the mean serum level of 17b-estradiol (115.9 AE 57.3 pgaml) was signi®cantly greater than the control group (P`0.05).
Decreased circulating levels of estrogen and hemodynamic changes during vaginal engorgement
Oophorectomy alone and oophorectomy followed by estrogen replacement therapy did not affect systemic arterial blood pressure (Table 1 ). In the control group, basal vaginal mucosal blood¯ow in the quiescent state was 15.0 AE 6.4 mlamina100 g tissue. During nerve stimulation-induced vaginal engorgement, vaginal mucosal blood¯ow signi®-cantly increased to a peak level of 48.9 AE 6.5 mlamina100 g tissue (P`0.05; Figure 1 ). In the O group, basal vaginal mucosal blood¯ow in the quiescent state (16.7 AE 11.8 mlamina100 g tissue) was comparable to the control group (P b 0.05; Figure 1 ). However, peak vaginal blood¯ow during nerve stimulation-induced vaginal engorgement (28.9 AE 16.3 mlamina100 g tissue) was signi®cantly less than peak vaginal mucosal blood¯ow in the control group (P`0.05). Both basal vaginal mucosal blood¯ow in the quiescent state and peak vaginal mucosal blood¯ow during nerve stimulation induced engorgement in the OE group (20.4 AE 8.4 and 48.7 AE 12.2 mlamina100 g tissue, respectively) were comparable to those recorded in the control group (P b 0.05; Figure 1 ).
Decreased circulating levels of estrogen and hemodynamic changes during clitoral engorgement
In the control group, clitoral intracavernosal blood ow signi®cantly increased during nerve stimulation-induced clitoral engorgement from a basal level of 3.8 AE 1.6 mlamina100 g tissue to a peak level of 11.0 AE 2.4 mlamina100 g tissue (Figure 2 ). In the O group, basal clitoral intracavernosal blood¯ow (3.5 AE 0.3 mlamina100 g tissue) was comparable to the control group (P b 0.05). However, peak clitoral intracavernosal blood¯ow during nerve stimulation-induced clitoral engorgement (6.1 AE 1.4 mlamina100 g tissue) was signi®cantly less than the control group (P`0.05; Figure 2 ). In the OE group, both basal clitoral intracavernosal blood¯ow (4.7 AE 1.4 mlamina100 g tissue) and peak clitoral intracavernosal blood¯ow during engorgement (10.1 AE 2.8 mlamina100 g tissue) were comparable to the control group (P`0.05; Figure 2 ). Figure 5 ). and OE (C) groups. The peak clitoral intracavernosal blood¯ow during clitoral engorgement is signi®cantly decreased in the O group compared with the control and OE groups. The peak clitoral intracavernosal blood¯ow in the OE group is comparable to the control group.
Estrogen deprivation and pathophysiological changes in the vagina and clitoris K Park et al
Discussion
Decline in the circulating levels of estrogen is a major physiologic change during natural menopause. It has been reported that female sexual arousal function correlates negatively with menopausal symptoms such as hot¯ushes. 9 Menopause related ovarian atrophy and decreased levels of estrogen have been shown to cause marked decrease Estrogen deprivation and pathophysiological changes in the vagina and clitoris K Park et al in vaginal lubrication. 2 The reduced estrogen levels in the menopausal state has also been associated with lack of orgasm, delayed orgasm and painful intercourse. 10 While the relationship between decreased estrogen and the development of sexual arousal dysfunction has been frequently reported, the impact of estrogen de®ciency on the hemodynamic mechanism of clitoral and vaginal engorgement has not been investigated previously.
In the present study we utilized a rabbit model of bilateral oophorectomy to determine the effects of decreased levels of circulating estrogen on clitoral and vaginal blood¯ows before and then during clitoral and vaginal engorgement. Several studies have shown that lack of blood¯ow alters the structure of a variety of organs including the penis. 11 We, therefore, attempted to study whether oophorectomy-induced long-term hemodynamic changes in the vagina and clitoris interfere with their structure. To examine prophylactic measures of oophorectomy-induced functional and structural changes in the vagina and clitoris, we utilized a second model that underwent oophorectomy and received estrogen replacement therapy. These two models were studied in parallel with an agematched control group that did not undergo oophorectomy or estrogen treatment. We found that circulating levels of estrogen were signi®-cantly decreased after bilateral oophorectomy. Subcutaneous injection of estradiol was very effective in preserving the serum estrogen levels after oophorectomy.
Hemodynamic studies in the control animals showed that the mean vaginal mucosal blood¯ow in the quiescent vaginal state, prior to pelvic nerve stimulation was 15.0 AE 6.4 mlamina100 g. Stimulation of the vaginalaclitoral branch of the pelvic nerve resulted in a signi®cant increase in vaginal mucosal blood¯ow to 48.9 AE 6.5 mlamina100 g leading to the development of vaginal engorgement. In our previous studies we utilized a similar technique in the rabbit model and found that vaginal blood ow in the muscular layer of the vaginal wall in the quiescent vaginal state was 5.9 AE 2.6 mlamina100 g tissue. 7 We also found that blood¯ow in the muscular layer of the vagina increased to 13.9 AE 4.5 mlamina100 g during nerve stimulationinduced vaginal engorgement. 7 This would suggest that vaginal blood¯ow in the mucosal layer of the vagina is much greater compared with blood¯ow in the muscular layer in the quiescent vaginal state as well as during engorgement. Oophorectomyinduced decrease in the circulating levels of estrogen adversely affected vaginal mucosal blood¯ow. The peak vaginal blood¯ow during nerve stimulation-induced vaginal engorgement signi®cantly decreased in animals in the O group compared with control group. Vaginal blood¯ow restoration by estrogen replacement therapy further con®rms that oophorectomy-induced vaginal hemodynamic changes were related to a decline in the circulating levels of estrogen. The aforementioned decreased vaginal blood¯ow appears to be responsible for the development of vaginal engorgement insuf®ciency in animals in the O group. In addition to vaginal engorgement insuf®ciency, such a decrease in vaginal blood¯ow is likely to produce vaginal dryness, or decrease in the amount of vaginal lubrication.
While the relationship between estrogen levels and vaginal blood¯ow and structure have been investigated to some extent, the effect of decreased levels of estrogen on the clitoral intracavernosal blood¯ow and clitoral structure has not been reported previously. In a previous study we found that clitoral engorgement following stimulation of the vaginalaclitoral branch of the pelvic nerve depends on the increase of intracavernosal blood ow. 7 We also found that clitoral arterial insuf®-ciency diminished nerve stimulation-induced clitoral engorgement. In our present study, nerve stimulation signi®cantly increased clitoral intracavernosal blood¯ow in the control group. In the O group, however, nerve stimulation-induced peak clitoral intracavernosal blood¯ow was signi®cantly less than the control group, suggesting impairment of clitoral engorgement in the O group. Our studies in the O+E group showed that estrogen replacement therapy following oophorectomy was capable of preserving peak clitoral intracavernosal blood¯ow to the levels of the control group. Clinical studies have also demonstrated that older women had decreased baseline and post-stimulation clitoral arterial blood¯ow compared to younger women. 12 The precise mechanisms by which aging and decreased levels of estrogen interfere with vaginal Estrogen deprivation and pathophysiological changes in the vagina and clitoris K Park et al and clitoral intracavernosal blood¯ows are unknown. One possible mechanism by which decreased levels of estrogen impairs vaginal and clitoral blood¯ow may involve the nitric oxide (NO) pathway. It is believed that increased vaginal wall and clitoral intracavernosal blood¯ows in the arousal state results from relaxation of clitoral cavernosal and vaginal tissues and dilation of microvasculature. Our recent studies in the organ bath have shown that relaxation of the rabbit clitoral cavernosal smooth muscle is mediated by nitric oxide NO. 13 The vaginal tissue is also capable of relaxing via the NO pathway. 13 However, the primary mediator of the neurogenic relaxation of vaginal tissue is not known. Nitric oxide synthase (NOS) subtypes have been localized in human clitoral cavernosal tissue. 14 Hayashi et al reported that the vasoprotective effect of estrogen may be mediated by increasing the expression and activity of endothelial NOS. 15 Studies with the rat model have shown that oophorectomy-induced decrease in circulating levels of estrogen downregulated NOS subtype expression in the vaginal tissue. 8 Our histologic studies revealed that oophorectomy-induced decline in the circulating levels of estrogen caused atrophic changes in the vaginal mucosal layer, decreased vaginal submucosal microvasculature and led to loss of clitoral cavernosal smooth muscle. Association of atrophic changes in the mucosa and decreased submucosal microvasculature in our animal model may suggest the role of decreased arterial in¯ow in the development of structural changes in the vaginal mucosa. While prevention of structural damage by estrogen replacement therapy supports this hypothesis, it also suggests that decreased levels of estrogen may also directly interfere with vaginal structure, possibly by altering the expression of growth factors. This possibility may be further supported by studies of Hodgins et al demonstrating abundant estrogen receptors in the vaginal epithelium and smooth muscle. 16 Previous studies with the rat model have shown that estrogen withdrawal resulted in overall vaginal atrophy, diffuse intramural collagen accumulation and thickening of the perivascular wall. 8 In our studies with human clitoral cavernosal tissue we found that the percentage clitoral cavernosal smooth muscle decreased with age. 6 Studies with the rat model showed that decreased levels of estrogen lead to apoptosis in nerves, smooth muscle, vascular endothelium and epithelium of the rat vagina. 8 The precise mechanisms by which decreased levels of circulating estrogen lead to clitoral and vaginal structural changes are unknown. Evidence is accumulating from vascular tissue research that estrogen may directly modulate physiologic smooth muscle cell growth. 17, 18 It has been reported that estrogen inhibits mitogen-induced proliferation of vascular smooth muscle cells. 18 It has also been shown that estrogen is a potent inhibitor of the deposition of extracellular matrix proteins such as collagen. 18 Although functional receptors for estrogen exist in both vaginal and clitoral tissues, their role in the regulation of vaginal and clitoral structure and function has not been thoroughly investigated. 19, 20 Our present study, in conjunction with previous reports, suggests that physiologic levels of circulating estrogen may be of great importance in maintaining the normal hemodynamic necessary for vaginal and clitoral engorgement. Physiologic levels of estrogen also appear to play an important role in maintaining the normal structure of the vaginal wall and clitoral cavernosal tissue.
Conclusion
Our studies show that decline in the circulating levels of estrogen adversely affect the hemodynamic mechanism of vaginal and clitoral engorgement in the rabbit. Decreased levels of circulating estrogen also produced marked changes in the structure of vaginal and clitoral tissues leading to thinning of the vaginal epithelial layers, decreased vaginal submucosal vasculatures and diffuse clitoral cavernosal ®brosis. These observations suggest that female sexual arousal dysfunction in the menopausal state may result, in part, from structural and functional changes in the vagina and clitoris as a consequence of decreased levels of estrogen.
